Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| $823.4K |
| -29.4% |
| Open the original filing on SEC.gov |
| Jan 21 | NAMS | NewAmsterdam Pharma Co… | SSELL◷ | 15,422 | $33.25 | $512.8K | -15.7% | Open the original filing on SEC.gov |
| Jan 21 | NAMS | NewAmsterdam Pharma Co… | MEXER◷ | 39,784 | $9.26 | $368.4K | +68.1% | Open the original filing on SEC.gov |
| Jan 20 | NAMS | NewAmsterdam Pharma Co… | MEXER◷◆ | 60,216 | — | — | — | Open the original filing on SEC.gov |
| Jan 20 | NAMS | NewAmsterdam Pharma Co… | SSELL◷ | 19,604 | $32.38 | $634.8K | -25.1% | Open the original filing on SEC.gov |
| Jan 20 | NAMS | NewAmsterdam Pharma Co… | SSELL◷ | 39,712 | $31.78 | $1.3M | -33.7% | Open the original filing on SEC.gov |
| Jan 20 | NAMS | NewAmsterdam Pharma Co… | SSELL◷ | 900 | $30.64 | $27.6K | -0.8% | Open the original filing on SEC.gov |
| Jan 20 | NAMS | NewAmsterdam Pharma Co… | MEXER◷ | 60,216 | $9.26 | $557.6K | +103.1% | Open the original filing on SEC.gov |
| Jan 7 | NAMS | NewAmsterdam Pharma Co… | AGRANT◷◆ | 115,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | NAMS | NewAmsterdam Pharma Co… | AGRANT◷ | 25,500 | — | — | +77.5% | Open the original filing on SEC.gov |
| Jan 5 | NAMS | NewAmsterdam Pharma Co… | SSELL◷ | 5,118 | $33.25 | $170.2K | -13.5% | Open the original filing on SEC.gov |